Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
10/8/2024
AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal wort...
10/8/2024
MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...
10/3/2024
Recent Executive Moves
10/3/2024
Domestic Pharma Companies Saw Rapid Growth in Outlicensing Deals in 20...
10/3/2024
WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT
10/2/2024
Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
10/2/2024
CDE Solicits Comments on the Proposed BE Study Guidelines for Five Gen...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Writing...
10/2/2024
China Issues New Regulation on Network Data Security Management
10/2/2024
China Introduces Credit System for Hospital and Pharmacy Staff to Curb...
10/1/2024
China and US to Renew Health Cooperation Following Washington Talks
10/1/2024
AFT in China License Deal with Xizang Weixinkang Pharma for Maxigesic ...
10/1/2024
Haleon Plans to Raise Stake in Chinese JV to 88%
10/1/2024
LEO Pharma Submits NDA for Enstilar for Adults with Plaque Psoriasis i...
10/1/2024
Akeso's Cadonilimab Receives Second Indication Approval from NMPA
10/1/2024
Lepu Biopharma Files NDA for Lead Product EGFR ADC MRG003
10/1/2024
MediLink Registers Phase 3 Trial of Its B7H3 ADC YL201
10/1/2024
Regeneron and Sanofi Announced Chinese Approval of Dupixent as the Fir...
10/1/2024
Biotheus to Initiate Phase 3 Trial of BsAb PM8002 for SCLC
10/1/2024
AstraZeneca's Seeks Chinese Approval of Antisense Therapy Eplontersen ...
10/1/2024
NMPA Conditionally Approves Qilu's QL1706 (Iparomlimab + Tuvonralimab)...
10/1/2024
Akeso's Ebronucimab (PCSK9) Approved for Hypercholesterolemia in China
10/1/2024
Genentech to Acquire Regor Pharma’ Next-Generation CDK Inhibitor Port...
10/1/2024
Alphamab and CSPC Enter a Licensing Deal on Anti-HER2 BsADC JSKN003 in...
10/1/2024
InventisBio Prevails in Trade Secret Misappropriation Lawsuit Filed by...
10/1/2024
NH Reports MAT H1/2024 Data on the Chinese Cough, Cold and Allergy Mar...
10/1/2024
HUTCHMED Announces Japan Approval for FRUZAQLA (fruquintinib) Received...
10/1/2024
Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...
Page:
53
/
57
Total number of articles:
1697
:
[First]
[<<]
[51]
[52]
[53]
[54]
[55]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit